Insider · CIK 0001792722
Kevin Buehler
Files at DTIL (PRECISION BIOSCIENCES INC). First filing Dec 31, 2024, latest Jun 27, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DTIL: PRECISION BIOSCIENCES INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | PRECISION BIOSCIENCES INC | $21k 5,076 shares | +22% | +11% from low-60% from high | |
| 53Moderate | PRECISION BIOSCIENCES INC | $21k 4,523 shares | +52% | +19% from low-57% from high | |
| 48Moderate | PRECISION BIOSCIENCES INC | $21k 4,320 shares | +98% | +13% from low-56% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2025 | DTIL PRECISION BIOSCIENCES INC | POpen-market purchase Common Stock | +5,076 | $4.16 | $21k | 28,137 | Jun 27, 2025 |
| May 27, 2025 | DTIL PRECISION BIOSCIENCES INC | MOption exercise Common Stock | +9,826 | - | - | 23,061 | Jun 4, 2025 |
| May 27, 2025 | DTIL PRECISION BIOSCIENCES INC | MOption exercise Restricted Stock Unitsderivative | -9,826 | $0.00 | $0 | 0 | Jun 4, 2025 |
| Jun 3, 2025 | DTIL PRECISION BIOSCIENCES INC | AGrant or award Restricted Stock Unitsderivative | +21,000 | $0.00 | $0 | 21,000 | Jun 4, 2025 |
| Mar 26, 2025 | DTIL PRECISION BIOSCIENCES INC | POpen-market purchase Common Stock | +4,523 | $4.67 | $21k | 13,235 | Mar 28, 2025 |
| Dec 27, 2024 | DTIL PRECISION BIOSCIENCES INC | POpen-market purchase Common Stock | +4,320 | $4.88 | $21k | 8,712 | Dec 31, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.